Evidence map›Paper›PMID 28620279›Full record

ArticleFrontiers in neuroscience2017

Interleukin-6 Deficiency Attenuates Retinal Ganglion Cell Axonopathy and Glaucoma-Related Vision Loss.

Franklin D Echevarria, Cathryn R Formichella, Rebecca M Sappington

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Franklin D EchevarriaNeuroscience Graduate Program, Vanderbilt UniversityNashville, TN, United States.
Cathryn R FormichellaDepartment of Ophthalmology and Visual Sciences, Vanderbilt University School of MedicineNashville, TN, United States.
Rebecca M SappingtonDepartment of Ophthalmology and Visual Sciences, Vanderbilt University School of MedicineNashville, TN, United States.
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
Interleukin-6 and Retinal Ganglion Cell Degeneration in GlaucomaR01EY020496 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SAPPINGTON, REBECCA M · 2010 to 2020
$4.0M
NEI NIH HHS P30 EY008126NEI NIH HHS R01 EY020496NIGMS NIH HHS R25 GM062459
6 · The paper itself

Abstract

The pleotropic cytokine interleukin-6 (IL-6) is implicated in retinal ganglion cell (RGC) survival and degeneration, including that associated with glaucoma. IL-6 protects RGCs from pressure-induced apoptosis

Indexed as

axonopathycorneacytokineglaucomainterleukin-6microbeadretinal ganglion cellwound healing

Identifiers

PMID28620279
PMCPMC5450377
OpenAlexW2617912028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.